Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network-Reference-Cited by-同舟云学术

Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network

Published:2019-07 Issue:7 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Rhodes Nathaniel J.¹²^ORCID,Wagner Jamie L.³,Davis Susan L.⁴⁵,Bosso John A.⁶,Goff Debra A.⁷,Rybak Michael J.⁴,Scheetz Marc H.¹²⁸^ORCID,

Affiliation:

1. Department of Pharmacy Practice, Pharmacometrics Center of Excellence, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois, USA

2. Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA

3. Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, Mississippi, USA

4. Anti-infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA

5. Department of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan, USA

6. Department of Clinical Pharmacy and Outcome Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA

7. Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA

8. Department of Pharmacology, Midwestern University College of Graduate Studies, Downers Grove, Illinois, USA

Abstract

We sought to define trends in and predictors of carbapenem consumption across community, teaching, and university-affiliated hospitals in the United States and Canada. We conducted a retrospective multicenter survey of carbapenem and broad-spectrum noncarbapenem beta-lactam consumption between January 2011 and December 2013.

Funder

Merck

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00327-19

Reference35 articles.

1. National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion U.S. Department of Health and Human Services. 2013. Antibiotic resistance threats in the United States 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed January 2019.

2. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

3. Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification

4. Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

5. Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between carbapenem use and major diagnostic category in curative care beds: Analysis of a 2020 Japanese national administrative database;Journal of Infection and Chemotherapy;2023-11

2. Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study*;Critical Care Medicine;2023-05-26

3. Risk of relapse and readmission among hospitalized adults with carbapenem non-susceptible gram-negative infections;Current Medical Research and Opinion;2023-05-13

4. Association between Carbapenem Consumption and Clinical Outcomes in an In-Hospital Setting: Analysis of a Japanese Nationwide Administrative Database in 2020;Antibiotics;2022-12-13

5. Epidemiology of Nocardia Species at a Tertiary Hospital in Southern Taiwan, 2012 to 2020: MLSA Phylogeny and Antimicrobial Susceptibility;Antibiotics;2022-10-19